145 related articles for article (PubMed ID: 9836756)
21. Relation between butyrylcholinesterase K variant, paraoxonase 1 (PON1) Q and R and apolipoprotein E epsilon 4 genes in early-onset coronary artery disease.
Nassar BA; Darvesh S; Bevin LD; Rockwood K; Kirkland SA; O'Neill BJ; Bata IR; Johnstone DE; Title LM
Clin Biochem; 2002 May; 35(3):205-9. PubMed ID: 12074828
[TBL] [Abstract][Full Text] [Related]
22. Two types of sporadic cerebral amyloid angiopathy.
Thal DR; Ghebremedhin E; Rüb U; Yamaguchi H; Del Tredici K; Braak H
J Neuropathol Exp Neurol; 2002 Mar; 61(3):282-93. PubMed ID: 11895043
[TBL] [Abstract][Full Text] [Related]
23. The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations.
Crawford F; Fallin D; Suo Z; Abdullah L; Gold M; Gauntlett A; Duara R; Mullan M
Neurosci Lett; 1998 Jun; 249(2-3):115-8. PubMed ID: 9682830
[TBL] [Abstract][Full Text] [Related]
24. The butyrylcholinesterase K variant is a protective factor for sporadic Alzheimer's disease in women.
Alvarez-Arcaya A; Combarros O; Llorca J; Sánchez-Guerra M; Berciano J; Fernández-Viadero C; Peña N
Acta Neurol Scand; 2000 Dec; 102(6):350-3. PubMed ID: 11125748
[TBL] [Abstract][Full Text] [Related]
25. Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease.
Vijayaraghavan S; Darreh-Shori T; Rongve A; Berge G; Sando SB; White LR; Auestad BH; Witoelar A; Andreassen OA; Ulstein ID; Aarsland D
J Alzheimers Dis; 2016; 50(2):567-76. PubMed ID: 26757188
[TBL] [Abstract][Full Text] [Related]
26. Influence of apolipoprotein E genotype on cerebral amyloid angiopathy in the elderly.
Itoh Y; Yamada M; Suematsu N; Matsushita M; Otomo E
Stroke; 1996 Feb; 27(2):216-8. PubMed ID: 8571412
[TBL] [Abstract][Full Text] [Related]
27. Apolipoprotein E alleles and brain vascular pathology in Alzheimer's disease.
Kalaria RN; Cohen DL; Premkumar DR
Ann N Y Acad Sci; 1996 Jan; 777():266-70. PubMed ID: 8624096
[TBL] [Abstract][Full Text] [Related]
28. Age-dependent association between butyrylcholinesterase K-variant and Alzheimer disease-related neuropathology in human brains.
Ghebremedhin E; Thal DR; Schultz C; Braak H
Neurosci Lett; 2002 Mar; 320(1-2):25-8. PubMed ID: 11849755
[TBL] [Abstract][Full Text] [Related]
29. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
[TBL] [Abstract][Full Text] [Related]
30. Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study.
Chuang YF; Varma V; An Y; Tanaka T; Davatzikos C; Resnick SM; Thambisetty M
J Alzheimers Dis; 2020; 75(2):417-427. PubMed ID: 32250307
[TBL] [Abstract][Full Text] [Related]
31. Cerebral amyloid angiopathy in Alzheimer disease is associated with apolipoprotein E4 and cortical neuron loss.
Zarow C; Zaias B; Lyness SA; Chui H
Alzheimer Dis Assoc Disord; 1999 Jan; 13(1):1-8. PubMed ID: 10192636
[TBL] [Abstract][Full Text] [Related]
32. Interaction between CYP19 aromatase and butyrylcholinesterase genes increases Alzheimer's disease risk.
Combarros O; Riancho JA; Infante J; Sañudo C; Llorca J; Zarrabeitia MT; Berciano J
Dement Geriatr Cogn Disord; 2005; 20(2-3):153-7. PubMed ID: 16020944
[TBL] [Abstract][Full Text] [Related]
33. ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy.
Montañola A; de Retana SF; López-Rueda A; Merino-Zamorano C; Penalba A; Fernández-Álvarez P; Rodríguez-Luna D; Malagelada A; Pujadas F; Montaner J; Hernández-Guillamon M
Neuromolecular Med; 2016 Mar; 18(1):99-108. PubMed ID: 26661731
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for cerebral amyloid angiopathy in the elderly.
Yamada M
Ann N Y Acad Sci; 2002 Nov; 977():37-44. PubMed ID: 12480732
[TBL] [Abstract][Full Text] [Related]
35. Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype.
Tanskanen M; Lindsberg PJ; Tienari PJ; Polvikoski T; Sulkava R; Verkkoniemi A; Rastas S; Paetau A; Kiuru-Enari S
Neuropathol Appl Neurobiol; 2005 Dec; 31(6):589-99. PubMed ID: 16281907
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease.
Tilley L; Morgan K; Grainger J; Marsters P; Morgan L; Lowe J; Xuereb J; Wischik C; Harrington C; Kalsheker N
Eur J Hum Genet; 1999 Sep; 7(6):659-63. PubMed ID: 10482954
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage.
McCarron MO; Nicoll JA
Ann N Y Acad Sci; 2000 Apr; 903():176-9. PubMed ID: 10818505
[TBL] [Abstract][Full Text] [Related]
38. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
[TBL] [Abstract][Full Text] [Related]
39. High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy.
Nicoll JA; Burnett C; Love S; Graham DI; Dewar D; Ironside JW; Stewart J; Vinters HV
Ann Neurol; 1997 Jun; 41(6):716-21. PubMed ID: 9189032
[TBL] [Abstract][Full Text] [Related]
40. Butyrylcholinesterase K variant and Alzheimer's disease risk: a meta-analysis.
Wang Z; Jiang Y; Wang X; Du Y; Xiao D; Deng Y; Wang J
Med Sci Monit; 2015 May; 21():1408-13. PubMed ID: 25978873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
